Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

lumretuzumab

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Purpose This study investigated the safety and clinical activity of lumretuzumab, a humanised antihuman epidermal growth factor… Expand
Is this relevant?
2018
2018
SummaryPurpose To investigate the safety and clinical activity of comprehensive human epidermal growth factor receptor (HER… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2018
2018
PurposeTo inform lumretuzumab and pertuzumab dose modifications in order to decrease the incidence, severity, and duration of the… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2017
2017
Bidirectional cross talk between members of the human epidermal growth factor family of receptors (HER) and the estrogen receptor… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2017
2017
Purpose: This study investigated the safety, clinical activity, and target-associated biomarkers of lumretuzumab, a humanized… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2017
2017
Purpose: We evaluated biodistribution and tumor targeting of 89Zr-lumretuzumab before and during treatment with lumretuzumab, a… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2017
2017
AbstractPurposeThis study aimed at evaluating if pharmacokinetic and pharmacodynamic data from the first few patients treated… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2017
2017
Background: Inhibition of HER2 and HER3 heterodimerisation is a novel treatment concept in HER2-”low” expressing breast cancer… Expand
Is this relevant?
2016
2016
11555Background: Lumretuzumab is a humanized, glycoengineered, monoclonal antibody targeting human epidermal growth factor… Expand
Is this relevant?
2015
2015
Purpose: A first-in-human phase I study was conducted to characterize safety, efficacy, and pharmacokinetic (PK) and… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?